Latash Investments’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $805K | Hold |
243,134
| – | – | 0.62% | 8 |
|
|
2025
Q1 | $705K | Hold |
243,134
| – | – | 0.58% | 9 |
|
|
2024
Q4 | $866K | Hold |
243,134
| – | – | 0.68% | 9 |
|
|
2024
Q3 | $1.21M | Hold |
243,134
| – | – | 1.11% | 8 |
|
|
2024
Q2 | $632K | Hold |
243,134
| – | – | 0.51% | 12 |
|
|
2024
Q1 | $1.04M | Hold |
243,134
| – | – | 0.74% | 10 |
|
|
2023
Q4 | $491K | Hold |
243,134
| – | – | 0.35% | 14 |
|
|
2023
Q3 | $372K | Hold |
243,134
| – | – | 0.32% | 15 |
|
|
2023
Q2 | $401K | Hold |
243,134
| – | – | 0.32% | 17 |
|
|
2023
Q1 | $277K | Hold |
243,134
| – | – | 0.25% | 20 |
|
|
2022
Q4 | $219K | Hold |
243,134
| – | – | 0.18% | 22 |
|
|
2022
Q3 | $284K | Hold |
243,134
| – | – | 0.23% | 20 |
|
|
2022
Q2 | $156K | Hold |
243,134
| – | – | 0.13% | 22 |
|
|
2022
Q1 | $635K | Hold |
243,134
| – | – | 0.41% | 17 |
|
|
2021
Q4 | $946K | Hold |
243,134
| – | – | 0.59% | 14 |
|
|
2021
Q3 | $1.06M | Hold |
243,134
| – | – | 0.66% | 12 |
|
|
2021
Q2 | $965K | Buy |
+243,134
| New | +$965K | 0.61% | 12 |
|